Healthcare providers' perspectives on the acceptability and uptake of HPV vaccines in Zimbabwe

Healthcare providers' perspectives on the acceptability and uptake of HPV vaccines in Zimbabwe
复制标题

DOI:
10.1080/0167482x.2016.1199544
复制
发表时间:
2016-12-01
影响因子:
3.1
通讯作者:
Stewart, Donna E.
Stewart, Donna E.
中科院分区:
医学3区
文献类型:
--
作者:
Crann, Sara E.;Barata, Paula C.;Stewart, Donna E.

文献摘要

被引文献

相似文献

背景资料:人乳头瘤病毒(HPV)疫苗是预防宫颈癌的关键策略,特别是在津巴布韦这样的宫颈癌筛查率低的国家。在津巴布韦,宫颈癌是妇女癌症相关死亡的主要原因,但HPV疫苗尚未广泛使用。本研究检查了医疗保健提供者:(1)对津巴布韦目前医院在宫颈癌预防和治疗方面的做法和问题的看法;(2)对HPV和HPV疫苗的了解;(3)对津巴布韦引入HPV疫苗接种计划的看法,包括成功实施的潜在促进因素和障碍。深入的半结构化访谈进行了15个医疗服务提供者在津巴布韦的农村医院。访谈包括八个主要问题和一些反映研究目的的额外探索。数据进行了分析,使用主题analysis.Results:参与者报告说,妇女并不总是被筛查宫颈癌。关于HPV和HPV疫苗的知识水平普遍较低,但参与者提出了许多问题,表明他们希望了解更多。尽管他们高度支持在津巴布韦实施HPV疫苗接种计划,但他们也发现了一些可能的心理社会,文化和后勤障碍,包括成本,疫苗接种计划和医院基础设施。然而,与会者也提供了一些文化相关的解决方案,包括教育和社区engagement.Conclusion:这项研究提供了深入了解医疗保健提供者的障碍,实施和可能的解决方案,可以使用的政策制定者,从业人员和其他利益相关者,以促进成功实施即将到来的HPV免疫接种计划在津巴布韦。
Background: Human papillomavirus (HPV) vaccines are a critical strategy in the prevention of cervical cancer, especially in countries like Zimbabwe where cervical cancer screening rates are low. In Zimbabwe, cervical cancer is the leading cause of cancer-related deaths in women but the HPV vaccine is not yet widely available. This study examined healthcare providers': (1) perceptions of current hospital practices and issues in cervical cancer prevention and treatment in Zimbabwe; (2) knowledge of HPV and HPV vaccines; and (3) perspectives on introducing HPV vaccination programs in Zimbabwe, including potential facilitators and barriers to successful implementation.Method: In-depth semi-structured interviews were conducted at a rural hospital with 15 healthcare providers in Zimbabwe. Interviews included eight main questions and a number of additional probes that reflected the study's purpose. Data were analyzed using thematic analysis.Results: Participants reported that women are not consistently being screened for cervical cancer. There were generally low levels of knowledge about HPV and HPV vaccines, but participants asked many questions indicating a desire to learn more. Although they were highly supportive of implementing HPV vaccination programs in Zimbabwe, they also identified a number of likely psychosocial, cultural, and logistical barriers to successful implementation, including cost, vaccine schedule, and hospital infrastructure. However, participants also provided a number of culturally relevant solutions, including education and community engagement.Conclusion: This study provides insight from healthcare providers about barriers to implementation and possible solutions that can be used by policy makers, practitioners, and other stakeholders to facilitate the successful implementation of forthcoming HPV immunization programs in Zimbabwe.